Switching and combining dopamine agonists

H Reichmann; B Herting; A Mïller; U Sommer

doi:10.1007/s00702-003-0081-z

Switching and combining dopamine agonists

J Neural Transm (Vienna). 2003 Dec;110(12):1393-400. doi: 10.1007/s00702-003-0081-z. Epub 2003 Jan 1.

Authors

H Reichmann¹, B Herting, A Mïller, U Sommer

Affiliation

¹ Department of Neurology, Technical University of Dresden, Dresden, Germany. Heinz.Reichmann@mailbox-tu-dresden.de

PMID: 14666411
DOI: 10.1007/s00702-003-0081-z

Abstract

Switching from one dopamine agonist to another is common practice in the treatment of patients with Parkinson's disease. This paper describes some ideas on the most practical way to perform switching. In addition, it describes the possibilities of combining various dopamine agonists and discusses pros and cons for doing so.

Publication types

Review

MeSH terms

Antiparkinson Agents / adverse effects
Antiparkinson Agents / pharmacokinetics
Antiparkinson Agents / therapeutic use*
Dopamine Agonists / adverse effects
Dopamine Agonists / pharmacokinetics
Dopamine Agonists / therapeutic use*
Drug Therapy, Combination*
Humans
Parkinson Disease / drug therapy*
Practice Patterns, Physicians'*

Substances

Antiparkinson Agents
Dopamine Agonists